University Hospital Basel, Department for Medical Oncology
University Hospital Basel, Department for Medical Oncology
Basel, Switzerland1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| First-in-Human Study of the GDF-15 Neutralizing Antibody Visugromab (CTL-002) in Patients With Advanced Cancer (GDFATHER) | Solid Tumor, Adult | Active, not recruiting | Phase 1 / Phase 2 | 2026-08-19 | NCT04725474 |